A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies
- PMID: 7523537
- DOI: 10.1093/infdis/170.4.867
A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies
Abstract
A monoclonal antibody (MAb) to Moraxella catarrhalis O35E bound to a surface-exposed epitope of a proteinaceous antigen of this organism. The antigen, designated UspA, was present in every strain of the pathogen tested in a colony blot RIA. UspA had a molecular mass on SDS-PAGE that varied between 300 and 400 kDa, depending on the individual M. catarrhalis strain. Passive immunization of mice with the UspA-reactive Mab enhanced pulmonary clearance of M. catarrhalis. Use of this Mab to screen a M. catarrhalis genomic DNA library permitted identification of a recombinant bacteriophage expressing the M. catarrhalis UspA protein. The recombinant UspA protein was used in Western blot analysis with sera from patients with M. catarrhalis pneumonia. Convalescent-phase sera but not acute-phase sera from these patients contained antibodies to this M. catarrhalis surface protein, indicating that M. catarrhalis strains growing in vivo express this molecule.
Similar articles
-
Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model.J Infect Dis. 1993 Aug;168(2):469-72. doi: 10.1093/infdis/168.2.469. J Infect Dis. 1993. PMID: 8335988
-
Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.Infect Immun. 2001 Mar;69(3):1358-63. doi: 10.1128/IAI.69.3.1358-1363.2001. Infect Immun. 2001. PMID: 11179299 Free PMC article.
-
Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance.J Med Microbiol. 1998 Feb;47(2):159-68. doi: 10.1099/00222615-47-2-159. J Med Microbiol. 1998. PMID: 9879959
-
Vaccines for Moraxella catarrhalis.Vaccine. 2000 Dec 8;19 Suppl 1:S101-7. doi: 10.1016/s0264-410x(00)00287-5. Vaccine. 2000. PMID: 11163472 Review.
-
Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections.Microbes Infect. 2000 Apr;2(5):561-8. doi: 10.1016/s1286-4579(00)00310-5. Microbes Infect. 2000. PMID: 10865201 Review.
Cited by
-
Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.Infect Immun. 2005 May;73(5):2790-6. doi: 10.1128/IAI.73.5.2790-2796.2005. Infect Immun. 2005. PMID: 15845482 Free PMC article.
-
Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.Infect Immun. 2006 Nov;74(11):6377-86. doi: 10.1128/IAI.00702-06. Epub 2006 Sep 11. Infect Immun. 2006. PMID: 16966403 Free PMC article.
-
Direct interactions with influenza promote bacterial adherence during respiratory infections.Nat Microbiol. 2019 Aug;4(8):1328-1336. doi: 10.1038/s41564-019-0447-0. Epub 2019 May 20. Nat Microbiol. 2019. PMID: 31110359 Free PMC article.
-
Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function.Infect Immun. 2008 Nov;76(11):5330-40. doi: 10.1128/IAI.00573-08. Epub 2008 Aug 4. Infect Immun. 2008. PMID: 18678659 Free PMC article.
-
A protective epitope of Moraxella catarrhalis is encoded by two different genes.Infect Immun. 1997 Nov;65(11):4367-77. doi: 10.1128/iai.65.11.4367-4377.1997. Infect Immun. 1997. PMID: 9353007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
